Home › Compare › USYNF vs ABBV
USYNF yields 226.76% · ABBV yields 3.06%● Live data
📍 USYNF pulled ahead of the other in Year 1
Combined, USYNF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of USYNF + ABBV for your $10,000?
Unisync Corp., through its subsidiaries, manufactures and distributes garments in Canada. It operates in two segments, Peerless Garments LP and Unisync Group Limited. The company provides duty gear, footwear, and other accessories to fire, emergency medical services, and police and security sectors under the Carleton brand name; and service wear shirts, pants, and ties for law enforcement, fire, emergency medical, security, and correctional personnel under the Rapier brand name. It also offers professional workwear, insulated coverall, rugged workwear, outerwear, and rainwear apparel, as well as flame-resistant and safety clothing under the Hammill brand name. In addition, the company provides a line of flame-resistant work clothing under the DewLine Coveralls brand name; leatherwear; cold/wet weather outerwear garments to government organizations, including the armed forces, parks and forestry staff, RCMP, and other users under the Parkas brand name; stealth suits to various DND departments, paramilitary, police departments, and companies within the oil industry under the Gore-Tex brand name; and body measurement services under the Best-Fit name. Further, it designs, manufactures, and distributes corporate, public safety, and military uniforms under the Red the Uniform Tailor brand name; and offers corporate apparel under the York brand name, as well as public safety, and security and tactical products. The company was formerly known as ComWest Enterprise Corp. and changed its name to Unisync Corp. in August 2014. Unisync Corp. was founded in 1929 and is headquartered in Vancouver, Canada.
Full USYNF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.